StockData

My Size vs Exascale Labs

MYSZ and XLAB side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MYSZ and XLAB compare

My Size is the larger company, worth 154 times as much as Exascale Labs ($495K against $3.2K).

Exascale Labs grew revenue faster over the last twelve months (111% versus 67.3% for My Size).

My Size keeps more of each dollar of sales as profit, with a net margin of −66.7% compared with −82.1% at Exascale Labs.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMYSZXLAB
Size and price
Market cap$495K$3.2K
Share price$0.679$2.14
Change, 1 year−92.6%−78.7%
Change, 5 years−99.9%–
Beta (5Y)0.96−0.74
Employees4512
StockData Score
Total score77
Valuation score3 (better)1
Growth score22
Performance score1 (better)0
Health score14 (better)
Dividend score00
Valuation
P/S0.0×0.0× (better)
P/B0.2×–
FCF yield−995%–
Fair value$15.23–
Margin of safety95.5%–
Growth
Revenue growth (TTM)67.3%111% (better)
Revenue growth, 5Y average131%–
Profitability
Gross margin29.7% (better)16.3%
Operating margin−63.7%−32.4% (better)
Net margin−66.7% (better)−82.1%
FCF margin−43.4%–
Return on equity−155%–
Return on invested capital−185%–
Financial health
Debt / equity0.42–
Current ratio1.29 (better)0.20
Altman Z-score−17.43−9.96 (better)
Piotroski F-score25 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions3.2%–
Held by insiders–7.7%
Insider net buying, 12 months$5.3K–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.